Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ramzia I. El-Bagary, Shereen Mowaka, Ehab F. Elkady & Maria A. Attallah. (2016) Validated Spectrophotometric Methods for Determination of Weakly UV absorbed Perindopril Arginine in Bulk and Combined Dosage Form. Analytical Chemistry Letters 6:6, pages 766-782.
Read now
Read now
Jasper J Brugts & Maarten L Simoons. (2012) Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?. Expert Review of Cardiovascular Therapy 10:8, pages 1001-1009.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2010) Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility. Integrated Blood Pressure Control 3, pages 11-19.
Read now
Read now
Ho Yin Lo. (2010) Itk inhibitors: a patent review. Expert Opinion on Therapeutic Patents 20:4, pages 459-469.
Read now
Read now
Articles from other publishers (17)
Claudio Borghi, Arrigo FG Cicero, Davide Agnoletti & Giulia Fiorini. (2023) Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?. European Journal of Internal Medicine 110, pages 10-15.
Crossref
Crossref
Kylie Connolly, Romeo BatacanJr.Jr., Douglas Jackson, Rebecca Vella & Andrew Fenning. (2023) Perindopril prevents development of obesity and hypertension in middle aged diet-induced obese rat models of metabolic syndrome. Life Sciences 314, pages 121291.
Crossref
Crossref
Atilla Topcu, Ugur Kostakoglu, Tolga Mercantepe, Hulya K. Yilmaz, Levent Tumkaya & Huseyin A. Uydu. (2022) The cardioprotective effects of perindopril in a model of polymicrobial sepsis: The role of radical oxygen species and the inflammation pathway. Journal of Biochemical and Molecular Toxicology 36:8.
Crossref
Crossref
Babji Palakeeti, Pothuraju Nageswara Rao & Jugun Prakash Chinta. (2021) Development of new stability indicating UPLC-UV method for the extraction and quantification of perindopril and indapamide from human plasma. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
I. T. Murkamilov. (2021) Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril. The Clinician 14:3-4, pages 78-85.
Crossref
Crossref
Sahar S. Abd El‐Rahman & Hany M. Fayed. (2019) Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat. Journal of Tissue Engineering and Regenerative Medicine 13:12, pages 2131-2141.
Crossref
Crossref
Yi Tao, Sheng Wang, Lei Wang, Min Song & Taijun Hang. (2018) Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS/MS and its pharmacokinetic application. Journal of Pharmaceutical Analysis 8:5, pages 333-340.
Crossref
Crossref
Valentina Buda, Minodora Andor, Lucian Petrescu, Carmen Cristescu, Dana Baibata, Mirela Voicu, Melania Munteanu, Ioana Citu, Calin Muntean, Octavian Cretu & Mirela Tomescu. (2017) Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment. International Journal of Molecular Sciences 18:2, pages 348.
Crossref
Crossref
R. S. Dougan, O. O. Kazakova & M. I. Zahorodnyi. (2016) Периндоприл – квантово-фармакологічні властивості. Likarska sprava:7-8, pages 121-126.
Crossref
Crossref
Corey B. Simon, Brittany Lee-McMullen, Dane Phelan, Janine Gilkes, Christy S. Carter & Thomas W. Buford. (2015) The renin–angiotensin system and prevention of age-related functional decline: where are we now?. AGE 37:1.
Crossref
Crossref
J.J. Brugts, Hisatomi Arima, W. Remme, M. Bertrand, R. Ferrari, K. Fox, J. DiNicolantonio, S. MacMahon, J. Chalmers, F. Zijlstra, K. Caliskan, M.L. Simoons, J.J. Mourad, E. Boersma & K.M. Akkerhuis. (2014) The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology 176:3, pages 718-723.
Crossref
Crossref
Joanna Bojarska, Waldemar Maniukiewicz, Lesław Sieroń, Piotr Kopczacki, Krzysztof Walczyński & Milan Remko. (2012) Perindoprilat monohydrate. Acta Crystallographica Section C Crystal Structure Communications 68:11, pages o443-o446.
Crossref
Crossref
J. J. Brugts, M. P. M. de Maat, A. H. J. Danser, E. Boersma & M. L. Simoons. (2011) Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study. Netherlands Heart Journal 20:1, pages 24-32.
Crossref
Crossref
Ming-Kai Tsai, Ren-Long Jan, Ching-Hsiung Lin, Chang-Hung Kuo, San-Nan Yang, Huan-Nan Chen, Ming-Yii Huang & Chih-Hsing Hung. (2023) Suppressive Effects of Imidapril on Th1- and Th2-Related Chemokines in Monocytes. Journal of Investigative Medicine 59:7, pages 1141-1146.
Crossref
Crossref
Jasper J Brugts, Eric Boersma & Maarten L Simoons. (2010) Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit. Pharmacogenomics 11:8, pages 1115-1126.
Crossref
Crossref
Thomas F. Newton, Richard De La GarzaIIII & Ken Grasing. (2010) The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. Psychiatry Research 179:1, pages 96-100.
Crossref
Crossref
Yao Zhang, Lei Wang, Mei Zhou, Zhihao Zhou, Xiaole Chen, Tianbao Chen, HangFai Kwok, Craig Ivanyi & Chris Shaw. (2010) The structure of helokinestatin-5 and its biosynthetic precursor from Gila monster (Heloderma suspectum) venom: Evidence for helokinestatin antagonism of bradykinin-induced relaxation of rat tail artery smooth muscle. Peptides 31:8, pages 1555-1561.
Crossref
Crossref